Study at a glance
How are vitamin D, inflammation and iron availability linked?
This page summarises studies of vitamin D and iron availability in inflammatory bowel disease. Inflammation can raise hepcidin, a substance that reduces the release of iron from cells. Iron can therefore be present in the body but less available for making red blood cells. Ferritin, a measure linked to iron stores, can also rise during inflammation and needs to be interpreted in that context.
What did studies in children with inflammatory bowel disease find?
Lower vitamin D was associated with higher hepcidin and lower haemoglobin, the oxygen-carrying substance in red blood cells. This remained after researchers accounted for measured inflammation and other differences. The study observed relationships; it could not prove that low vitamin D caused the iron restriction.
What changed during treatment for bowel disease?
In a study following children through treatment, blood vitamin D rose by about 40% over two weeks. Hepcidin and C-reactive protein, a measured sign of inflammation, each fell by about 81%. Ferritin also fell. The children were receiving treatment for active bowel disease at the same time, so vitamin D cannot be credited with all these changes. Adult studies also found links between vitamin D measures and iron availability.
Can vitamin D replace treatment for the causes of anaemia?
Anaemia during inflammatory disease can have several causes, including blood loss, low iron stores and reduced iron release from cells. Nutritional and other disease-related factors also matter. Vitamin D may influence parts of this process without controlling it completely. These findings do not show that vitamin D supplements can replace investigation or treatment of iron deficiency, blood loss or inflammatory disease.
Read the full article below ↓Inflammation can restrict iron availability by increasing hepcidin, reducing ferroportin-mediated iron release and retaining iron within storage and recycling cells. Human inflammatory-bowel-disease studies show that vitamin D status can track with this physiology: lower vitamin D status has been associated with higher hepcidin and lower haemoglobin, while prospective treatment data show large reductions in hepcidin as vitamin D status and inflammatory activity improve. This creates an important connection among Vitamin D and Iron Metabolism, inflammation and anaemia. For the detailed evidence review, see Vitamin D, Inflammation and Anaemia-Related Iron Restriction: Full Study.
Inflammation changes what iron markers mean
Hepcidin rises during inflammatory signalling and reduces cellular iron export. Ferritin can also rise as an acute-phase reactant, so apparently adequate ferritin does not necessarily mean that iron is readily available for erythropoiesis.
This pathway overlaps with Vitamin D and Chronic Inflammation, but vitamin D is only one regulator within the inflammatory environment.
IBD studies show an association with hepcidin and haemoglobin
In children with inflammatory bowel disease, vitamin D insufficiency was associated with higher hepcidin and lower haemoglobin after adjustment for measured inflammation and other clinical variables. The design was observational, so it cannot prove that low vitamin D caused the iron restriction.
A prospective paediatric study found that after two weeks of treatment, 25(OH)D rose by about 40% while hepcidin and C-reactive protein each fell by approximately 81%. Ferritin also fell. Because active IBD was being treated at the same time, the changes cannot be assigned entirely to vitamin D.
Vitamin D may interact with more than one iron pathway
Later adult IBD work associated vitamin D sufficiency with higher transferrin saturation and linked higher 1,25(OH)₂D:25(OH)D ratios with lower hepcidin. Experimental work also suggested regulation of intestinal ceruloplasmin.
The different roles of circulating 25(OH)D and active 1,25(OH)₂D make Vitamin D Testing: 25-OH-D vs 1,25-OH₂-D relevant to interpreting these findings.
The evidence does not make vitamin D an anaemia treatment
Anaemia in inflammatory disease can result from blood loss, true iron deficiency, hepcidin-mediated restriction, reduced erythropoietin responsiveness and other nutritional or disease-related factors. Vitamin D can intersect with this network without controlling it completely.
The strongest conclusion is that vitamin D status can participate in inflammatory iron physiology. It is not evidence that vitamin D supplementation replaces investigation or treatment of iron deficiency, blood loss or inflammatory disease.
Scientific sources
Vitamin D Status Is Associated with Hepcidin and Hemoglobin Concentrations in Children with Inflammatory Bowel Disease. PMID: 28700535.
Vitamin D Decreases Hepcidin and Inflammatory Markers in Newly Diagnosed Inflammatory Bowel Disease Paediatric Patients: A Prospective Study. PMID: 30840757.
Iron Deficiency in Inflammatory Bowel Disease Is Associated With Low Levels of Vitamin D Modulating Serum Hepcidin and Intestinal Ceruloplasmin Expression. PMID: 35029158.
Related reading
Vitamin D, Inflammation and Anaemia-Related Iron Restriction: Full Study
Evidence linking vitamin D status with inflammation, hepcidin, iron restriction and haemoglobin in inflammatory disease.
Read more →Alterations in regulators of the renal-bone axis, inflammation and iron status in older people with early renal impairment and the effect of vitamin D supplementation
Markers of the renal-bone axis, inflammation and iron status were investigated pre: and post-supplementation.
Original paper ↗Read more →Intact FGF23 and Markers of Iron Homeostasis, Inflammation, and Bone Mineral Metabolism in Acute Pediatric Infections
The aim of this prospective clinical study is to evaluate the association of i-FGF23 with hepcidin and markers of iron homeostasis, erythropoiesis, inflammation, and bone mineral metabolism in acute pediatric infections.
Original paper ↗Read more →Multiple Indicators of Undernutrition, Infection, and Inflammation in Lactating Women Are Associated with Maternal Iron Status and Infant Anthropometry in Panama: The MINDI Cohort
Maternal infections, nutrient deficiencies, and inflammation (MINDI) co-exist in lactating indigenous women in Panama, but their impact on maternal iron status and infant growth is unknown.
Original paper ↗Read more →Multiple Infections, Nutrient Deficiencies, and Inflammation as Determinants of Anemia and Iron Status during Pregnancy: The MINDI Cohort
In pregnant women with multiple infections, nutrient deficiencies, and inflammation (MINDI), the study of anemia and iron status is limited.
Original paper ↗Read more →Segregating the effects of ferric citrate‐mediated iron utilization and FGF23 in a mouse model of CKD
Ferric citrate (FC) is an approved therapy for chronic kidney disease (CKD) patients as a phosphate (Pi) binder for dialysis‐dependent CKD, and for iron deficiency anemia (IDA) in non‐dialysis CKD.
Original paper ↗Read more →The Effect of Vitamin D Supplementation on Hepcidin, Iron Status, and Inflammation in Pregnant Women in the United Kingdom
Our aim was to identify whether antenatal vitamin D3 supplementation affects iron status (via hepcidin suppression) and/or inflammation.
Original paper ↗Read more →Assessment of Vitamin D status and association with inflammation: Biomarkers Reflecting Inflammation and Nutritional Determinants of Anemia (BRINDA) project
We examined correlations between inflammation biomarkers, CRP or alpha-1-acid glycoprotein (AGP), and serum 25(OH)D concentrations among preschool children (PSC; 6 to 59 mo) and nonpregnant females of reproductive age (FRA; 15 to 49 y).
Original paper ↗Read more →An Inflammation-Adjusted Framework for Nutritional Assessment in Multimorbid Patients with Advanced Neurological Diseases
Background and Objectives: Laboratory parameters associated with nutritional and metabolic status may be substantially influenced by inflammatory activity, complicating their interpretation in patients with advanced neurological diseases.
Original paper ↗Read more →Association of systemic inflammation indices with micronutrient status in adult patients with celiac disease
We evaluated the association between systemic inflammation indices and micronutrient status in adults with celiac disease.
Original paper ↗Read more →Vitamin D as a modulator of pain and inflammation in postmenopausal females with burning mouth syndrome
The aim of this study was to investigate relationship between vitamin D levels and clinical features in postmenopausal females with burning mouth syndrome (BMS).
Original paper ↗Read more →Determinants of iron deficiency and anemia among Nunavimmiut: results from the Qanuilirpitaa? 2017 Nunavik Health Survey
To estimate the prevalence of iron deficiency (ID) and anemia and study their main distal and proximal protective and risk factors among Nunavimmiut 16 years and older in 2017.
Original paper ↗Read more →Vitamin D Deficiency and Its Association with Iron Deficiency in African Children
Vitamin D regulates the master iron hormone hepcidin, and iron in turn alters vitamin D metabolism.
Original paper ↗Read more →Vitamin D Supplementation and Clinical Iron Markers Across Populations: Study Summary
A concise review of why vitamin D supplementation produces variable effects on iron markers and haemoglobin across populations.
Read more →Micronutrients, Vitamin D, and Inflammatory Biomarkers in COVID-19: A Systematic Review and Meta-analysis of Causal Inference Studies
The aim was to conduct a systematic review and meta-analysis of causal inference studies that apply MR approaches to assess the role of these micronutrients, particularly VD, in COVID-19 risk, infection severity, and related inflammatory markers.
Original paper ↗Read more →Effect of Paricalcitol vs Calcitriol on Hemoglobin Levels in Chronic Kidney Disease Patients: A Randomized Trial
Therefore, we conducted a study to determine whether paricalcitol, compared to calcitriol, improves anemia in patients with chronic kidney disease (CKD).
Original paper ↗Read more →Micronutrient Status of Critically Ill Patients with COVID-19 Pneumonia
Micronutrient deficiencies can develop in critically ill patients, arising from factors such as decreased intake, increased losses, drug interactions, and hypermetabolism.
Original paper ↗Read more →Nutritional status and household food security of pregnant women: insights from the Nutritional Status of Expectant Mothers and their Newborn Infants (NuEMI) study in South Africa
26·7 % of participants were food secure, while 11·5 %, 32·1 % and 29·5 % experienced mild, moderate and severe food insecurity, respectively.
Original paper ↗Read more →Pre-operative micronutrient deficiencies in patients with severe obesity candidates for bariatric surgery
Our objective was to assess in pre-BS patients the prevalence of micronutrient deficiencies and their correlation with blood values of C-reactive protein (CRP).
Original paper ↗Read more →Vitamin D and Chronic Inflammation
Explains how vitamin D relates to chronic inflammation, including cytokine balance, immune regulation, metabolic links, and long-term inflammatory signalling, without making treatment claims.
Read more →Vitamin D and Iron Metabolism
Explore how vitamin D interacts with iron metabolism through immune and inflammatory regulation, gut health, and cellular signalling.
Read more →Original sources
Vitamin D Status Is Associated with Hepcidin and Hemoglobin Concentrations in Children with Inflammatory Bowel Disease
Vitamin D Status Is Associated with Hepcidin and Hemoglobin Concentrations in Children with Inflammatory Bowel Disease.
Publication details
Vitamin D Status Is Associated with Hepcidin and Hemoglobin Concentrations in Children with Inflammatory Bowel Disease. PMID: 28700535.
Vitamin D Decreases Hepcidin and Inflammatory Markers in Newly Diagnosed Inflammatory Bowel Disease Paediatric Patients: A Prospective Study
Vitamin D Decreases Hepcidin and Inflammatory Markers in Newly Diagnosed Inflammatory Bowel Disease Paediatric Patients: A Prospective Study.
Publication details
Vitamin D Decreases Hepcidin and Inflammatory Markers in Newly Diagnosed Inflammatory Bowel Disease Paediatric Patients: A Prospective Study. PMID: 30840757.
Iron Deficiency in Inflammatory Bowel Disease Is Associated With Low Levels of Vitamin D Modulating Serum Hepcidin and Intestinal Ceruloplasmin Expression
Iron Deficiency in Inflammatory Bowel Disease Is Associated With Low Levels of Vitamin D Modulating Serum Hepcidin and Intestinal Ceruloplasmin Expression.
Publication details
Iron Deficiency in Inflammatory Bowel Disease Is Associated With Low Levels of Vitamin D Modulating Serum Hepcidin and Intestinal Ceruloplasmin Expression. PMID: 35029158.